Summit Healthcare Acquisition Corp. Warrant
SMIHW
SMIHW was delisted on the 16th of March, 2023.
0 hedge funds and large institutions have $0 invested in Summit Healthcare Acquisition Corp. Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 24 closing their positions.
100% less funds holding
Funds holding: 24 → 0 (-24)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $19.8M → $0 (-$19.8M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 24
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$10.4M |
| 2 |
SCM
Segantii Capital Management
Hong Kong
|
-$6.01M |
| 3 |
AC
Athos Capital
Hong Kong
|
-$1.5M |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$1M |
| 5 |
BP
BFAM Partners
Northpoint, Hong Kong,
Hong Kong
|
-$156K |
SMIHW Hedge Fund Activity: Q1 2023 in Review
0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Summit Healthcare Acquisition Corp. Warrant (SMIHW) for Q1 2023, worth a combined $0 — down 100% from $19.8M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of SMIHW and 0 opened new positions — a net loss of 24 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $10.4M sold.
- 0 institutional investors held Summit Healthcare Acquisition Corp. Warrant (SMIHW) as of Q1 2023, down from 24 in Q4 2022.
- Funds reported $0 of Summit Healthcare Acquisition Corp. Warrant stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new Summit Healthcare Acquisition Corp. Warrant positions in Q1 2023 and 24 closed out, a net change of -24 holders.
- The largest Summit Healthcare Acquisition Corp. Warrant seller in Q1 2023 was LMR Partners, an estimated $10.4M sold.
Based on aggregated 13F filings for Q1 2023.